WODC Europe, 2023
— Emilie Dubernay
Related articles
Innovative industry perspective: Assessing the proposed regulatory changes and their impact on innovation and competitiveness of the EU regulatory framework as part of the EU General Pharmaceutical Legislation revision
European Policy10/10/2025
Rare disease policy in high-income countries: An overview of achievements, challenges, and solutions
European PolicyRare DiseasesUS Policy10/05/2025
Revision of the General Pharmaceutical Legislation: Impact assessment of key orphan proposals on Member States
European PolicyRare Diseases11/05/2024
Revision of the General Pharmaceutical Legislation: Impact assessment of European Commission and EFPIA proposals
European Policy23/11/2023